Stockreport

Stemline Therapeutics: Post-ASH Update For This Leader In The CD123 Space [Seeking Alpha]

STEMLINE THERAPEUTICS  (STML) 
Last stemline therapeutics earnings: 3/13 04:45 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.stemline.com/investor-relations
PDF Summary Shares have lost a third of their value since my August recommendation. I provide a recap of the bullish thesis and recent events. Opportunity for ELZONRIS in CM [Read more]